Business Context and Reporting Period
Company: GENCO SHIPPING & TRADING LTD
Filing Type: Form 8-K (Current Report)
Report Date: June 3, 2016
Event Date: May 31, 2016
Context: The filing reports the extension of waivers and cure periods regarding collateral maintenance covenants under three distinct credit facilities.
Key Financial Metrics and Debt Obligations
The filing does not provide specific revenue, profit, cash flow, or margin data. It focuses exclusively on debt covenant compliance for the following facilities:
- $253 Million Term Loan Facility: Waivers for collateral maintenance covenants extended.
- $100 Million Credit Facility: Waivers for collateral maintenance covenants extended.
- $148 Million Credit Facility: Cure period for a current shortfall under the collateral maintenance covenant extended.
Material Changes Versus Prior Period
The material change reported is the extension of previously disclosed waiver and cure periods:
- Previous Status: Waivers and cure periods were in effect through May 31, 2016.
- New Status: Agreements entered into on May 31, 2016, extended these waivers and cure periods through June 8, 2016.
- Parties Involved: Extensions were secured with Deutsche Bank, Crédit Agricole, Nordea Bank Finland plc, and Skandinaviska Enskilda Banken AB (SEB).
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the Company's ongoing efforts to manage covenant compliance through negotiated extensions with lenders.
Risks and Contingencies: The Company is currently in a state of non-compliance with collateral maintenance covenants across multiple facilities. The extension of the cure period to June 8, 2016, indicates a temporary resolution to avoid immediate default, but the underlying shortfall remains a material risk until resolved.
Unusual Items: The filing highlights a "current shortfall" under the $148 Million Credit Facility, necessitating the extended cure period.
Investor Verification Checklist
- Verify the status of the collateral shortfall as of June 8, 2016, to determine if the cure period was successfully utilized.
- Confirm whether further extensions or covenant waivers were required after June 8, 2016.
- Review subsequent filings for any default events triggered by the failure to cure the shortfall.
- Assess the impact of these covenant issues on the Company's ability to secure future financing.